(S)-nicotine increases expression ISO CSNK2A1 (Homo sapiens) 6480464 Nicotine results in increased expression of CSNK2A1 protein CTD PMID:35929799 (S)-nicotine multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 CHRNA7 affects the reaction [Nicotine results in increased expression of CSNK2A1 protein] more ... CTD PMID:35929799 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO Csnk2a1 (Mus musculus) 6480464 o and p'-DDT results in increased expression of CSNK2A1 mRNA CTD PMID:24096037 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o and p'-DDT results in increased expression of CSNK2A1 mRNA CTD PMID:24096037 1,2-dimethylhydrazine multiple interactions ISO Csnk2a1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSNK2A1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO Csnk2a1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CSNK2A1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Csnk2a1 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of CSNK2A1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CSNK2A1 mRNA CTD PMID:24096037 and PMID:29097150 17alpha-ethynylestradiol increases expression ISO Csnk2a1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of CSNK2A1 mRNA CTD PMID:17942748 and PMID:24096037 17alpha-ethynylestradiol multiple interactions ISO Csnk2a1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSNK2A1 mRNA CTD PMID:17942748 17beta-estradiol increases activity ISO CSNK2A1 (Homo sapiens) 6480464 Estradiol results in increased activity of CSNK2A1 protein CTD PMID:16901965 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO Csnk2a1 (Mus musculus) 6480464 Dihydrotestosterone results in decreased expression of CSNK2A1 mRNA CTD PMID:17023530 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Csnk2a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CSNK2A1 mRNA CTD PMID:18343893 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CSNK2A1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Csnk2a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CSNK2A1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Csnk2a1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSNK2A1 mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CSNK2A1 promoter] CTD PMID:17942748 and PMID:19654925 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO Csnk2a1 (Mus musculus) 6480464 2 more ... CTD PMID:18343893 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of CSNK2A1 mRNA CTD PMID:21346803 2-methoxyethanol decreases expression EXP 6480464 methyl cellosolve results in decreased expression of CSNK2A1 mRNA CTD PMID:19643169 3,3',4,4',5-pentachlorobiphenyl affects expression ISO CSNK2A1 (Homo sapiens) 6480464 3 more ... CTD PMID:21703328 3,3',5,5'-tetrabromobisphenol A decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of CSNK2A1 protein CTD PMID:31675489 3,4-methylenedioxymethamphetamine increases expression ISO Csnk2a1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of CSNK2A1 mRNA CTD PMID:19285098 4,4'-diaminodiphenylmethane decreases expression ISO Csnk2a1 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of CSNK2A1 mRNA CTD PMID:18648102 4,5,6,7-TETRABROMOBENZOTRIAZOLE multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 4 more ... CTD PMID:22317921 4-vinylcyclohexene dioxide affects expression ISO Csnk2a1 (Mus musculus) 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of CSNK2A1 mRNA CTD PMID:20829426 5-aza-2'-deoxycytidine increases activity ISO CSNK2A1 (Homo sapiens) 6480464 Decitabine results in increased activity of CSNK2A1 protein CTD PMID:19027835 5-aza-2'-deoxycytidine increases expression ISO CSNK2A1 (Homo sapiens) 6480464 Decitabine results in increased expression of CSNK2A1 mRNA and Decitabine results in increased expression of CSNK2A1 protein CTD PMID:19027835 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CSNK2A1 mRNA CTD PMID:31881176 acetylsalicylic acid increases expression ISO CSNK2A1 (Homo sapiens) 6480464 Aspirin results in increased expression of CSNK2A1 mRNA CTD PMID:11906190 acetylsalicylic acid decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 Aspirin results in decreased expression of CSNK2A1 mRNA CTD PMID:11906190 aconitine increases expression ISO CSNK2A1 (Homo sapiens) 6480464 Aconitine results in increased expression of CSNK2A1 protein CTD PMID:32234357 aconitine decreases expression EXP 6480464 Aconitine results in decreased expression of CSNK2A1 protein CTD PMID:33236894 acrolein multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CSNK2A1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CSNK2A1 mRNA CTD PMID:32699268 acrylamide decreases expression ISO Csnk2a1 (Mus musculus) 6480464 Acrylamide results in decreased expression of CSNK2A1 mRNA CTD PMID:21319176 aflatoxin B1 decreases methylation ISO CSNK2A1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of CSNK2A1 gene CTD PMID:27153756 alpha-pinene multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CSNK2A1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CSNK2A1 mRNA CTD PMID:32699268 alternariol decreases activity ISO CSNK2A1 (Homo sapiens) 6480464 alternariol results in decreased activity of CSNK2A1 protein CTD PMID:32328700 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CSNK2A1 mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO CSNK2A1 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of CSNK2A1 protein CTD PMID:33212167 Aroclor 1254 decreases expression ISO Csnk2a1 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CSNK2A1 mRNA CTD PMID:23650126 arsane increases expression ISO CSNK2A1 (Homo sapiens) 6480464 Arsenic results in increased expression of CSNK2A1 mRNA CTD PMID:19945496 arsenic atom increases expression ISO CSNK2A1 (Homo sapiens) 6480464 Arsenic results in increased expression of CSNK2A1 mRNA CTD PMID:19945496 arsenite(3-) affects expression ISO CSNK2A1 (Homo sapiens) 6480464 arsenite affects the expression of CSNK2A1 mRNA CTD PMID:22959463 ATP multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 silmitasertib inhibits the reaction [Adenosine Triphosphate binds to [CSNK2A1 protein binds to CSNK2A1 protein binds to CSNK2B protein binds to CSNK2B protein]] CTD PMID:21174434 ATP affects binding ISO CSNK2A1 (Homo sapiens) 6480464 Adenosine Triphosphate binds to [CSNK2A1 protein binds to CSNK2A1 protein binds to CSNK2B protein binds to CSNK2B protein] CTD PMID:21174434 benzene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of CSNK2A1 mRNA CTD PMID:17905399 benzo[a]pyrene increases methylation ISO CSNK2A1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of CSNK2A1 5' UTR CTD PMID:27901495 benzo[e]pyrene increases methylation ISO CSNK2A1 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of CSNK2A1 intron CTD PMID:30157460 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CSNK2A1 gene CTD PMID:28505145 bisphenol A increases expression ISO CSNK2A1 (Homo sapiens) 6480464 bisphenol A results in increased expression of CSNK2A1 mRNA CTD PMID:30809271 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CSNK2A1 mRNA CTD PMID:30816183 more ... bisphenol A affects expression ISO CSNK2A1 (Homo sapiens) 6480464 bisphenol A affects the expression of CSNK2A1 mRNA CTD PMID:30903817 Bisphenol B increases expression ISO CSNK2A1 (Homo sapiens) 6480464 bisphenol B results in increased expression of CSNK2A1 protein CTD PMID:34186270 cadmium dichloride decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of CSNK2A1 mRNA CTD PMID:25851441 cadmium dichloride increases expression ISO CSNK2A1 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of CSNK2A1 mRNA CTD PMID:33129824 capsaicin increases phosphorylation ISO CSNK2A1 (Homo sapiens) 6480464 Capsaicin results in increased phosphorylation of CSNK2A1 protein CTD PMID:20510015 carbamazepine affects expression ISO CSNK2A1 (Homo sapiens) 6480464 Carbamazepine affects the expression of CSNK2A1 mRNA CTD PMID:24752500 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of CSNK2A1 mRNA CTD PMID:23125180 cilostazol increases phosphorylation ISO Csnk2a1 (Mus musculus) 6480464 cilostazol results in increased phosphorylation of CSNK2A1 protein CTD PMID:24254769 cilostazol multiple interactions ISO Csnk2a1 (Mus musculus) 6480464 (E)-3-(2 more ... CTD PMID:24254769 cisplatin decreases expression ISO Csnk2a1 (Mus musculus) 6480464 Cisplatin results in decreased expression of CSNK2A1 mRNA CTD PMID:21151649 clobetasol increases expression ISO Csnk2a1 (Mus musculus) 6480464 Clobetasol results in increased expression of CSNK2A1 mRNA CTD PMID:27462272 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of CSNK2A1 mRNA CTD PMID:16715494 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of CSNK2A1 mRNA CTD PMID:12117546 copper atom multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of CSNK2A1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of CSNK2A1 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO CSNK2A1 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of CSNK2A1 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO Csnk2a1 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of CSNK2A1 mRNA CTD PMID:29279043 cyclosporin A increases expression ISO CSNK2A1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of CSNK2A1 mRNA CTD PMID:20106945 more ... decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of CSNK2A1 mRNA CTD PMID:23640034 decabromodiphenyl ether decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 decabromobiphenyl ether results in decreased expression of CSNK2A1 protein CTD PMID:31675489 diclofenac affects expression ISO CSNK2A1 (Homo sapiens) 6480464 Diclofenac affects the expression of CSNK2A1 mRNA CTD PMID:24752500 dieldrin decreases response to substance ISO CSNK2A1 (Homo sapiens) 6480464 CSNK2A1 gene mutant form results in decreased susceptibility to Dieldrin CTD PMID:32421776 dorsomorphin multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSNK2A1 mRNA CTD PMID:27188386 elemental selenium decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 Selenium results in decreased expression of CSNK2A1 mRNA CTD PMID:19244175 emodin increases expression ISO Csnk2a1 (Mus musculus) 6480464 Emodin results in increased expression of CSNK2A1 mRNA CTD PMID:21319176 enzyme inhibitor multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CSNK2A1 protein CTD PMID:23301498 ethyl methanesulfonate decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of CSNK2A1 mRNA CTD PMID:23649840 finasteride increases expression EXP 6480464 Finasteride results in increased expression of CSNK2A1 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CSNK2A1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO Csnk2a1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSNK2A1 mRNA CTD PMID:22206623 formaldehyde decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of CSNK2A1 mRNA CTD PMID:23649840 formaldehyde multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 Formaldehyde affects the localization of and affects the phosphorylation of CSNK2A1 protein more ... CTD PMID:36534342 geldanamycin increases expression ISO CSNK2A1 (Homo sapiens) 6480464 geldanamycin results in increased expression of CSNK2A1 mRNA CTD PMID:26705709 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CSNK2A1 mRNA CTD PMID:22061828 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of CSNK2A1 mRNA CTD PMID:16715494 ionomycin multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 Ionomycin promotes the reaction [EGF protein promotes the reaction [CSNK2A1 protein binds to SLC39A7 protein]] CTD PMID:22317921 ivermectin decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of CSNK2A1 protein CTD PMID:32959892 KT 5720 multiple interactions ISO Csnk2a1 (Mus musculus) 6480464 KT 5720 inhibits the reaction [cilostazol results in increased phosphorylation of CSNK2A1 protein] CTD PMID:24254769 methapyrilene increases methylation ISO CSNK2A1 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of CSNK2A1 intron CTD PMID:30157460 methyl methanesulfonate decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of CSNK2A1 mRNA CTD PMID:23649840 methylmercury(1+) multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of CSNK2A1 mRNA CTD PMID:17905399 N-Vinyl-2-pyrrolidone multiple interactions EXP 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of CSNK2A1 mRNA CTD PMID:22037397 nickel sulfate decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of CSNK2A1 mRNA CTD PMID:22714537 nicotine multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 CHRNA7 affects the reaction [Nicotine results in increased expression of CSNK2A1 protein] more ... CTD PMID:35929799 nicotine increases expression ISO CSNK2A1 (Homo sapiens) 6480464 Nicotine results in increased expression of CSNK2A1 protein CTD PMID:35929799 ochratoxin A decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 ochratoxin A results in decreased expression of CSNK2A1 mRNA CTD PMID:30559759 ozone multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CSNK2A1 mRNA more ... CTD PMID:32699268 and PMID:35430440 paracetamol increases expression ISO Csnk2a1 (Mus musculus) 6480464 Acetaminophen results in increased expression of CSNK2A1 protein CTD PMID:19679878 PCB138 affects expression ISO CSNK2A1 (Homo sapiens) 6480464 2 more ... CTD PMID:21703328 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CSNK2A1 mRNA CTD PMID:22037397 phenobarbital affects expression ISO Csnk2a1 (Mus musculus) 6480464 Phenobarbital affects the expression of CSNK2A1 mRNA CTD PMID:23091169 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of CSNK2A1 mRNA CTD PMID:18158353 potassium dichromate decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 Potassium Dichromate results in decreased expression of CSNK2A1 mRNA CTD PMID:11678601 pyrithione multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 2-dimethylamino-4 more ... CTD PMID:22317921 quercetin affects binding ISO CSNK2A1 (Homo sapiens) 6480464 Quercetin analog binds to CSNK2A1 protein CTD PMID:21798748 quercetin decreases activity ISO CSNK2A1 (Homo sapiens) 6480464 Quercetin results in decreased activity of CSNK2A1 protein CTD PMID:32328700 quercitrin affects expression ISO CSNK2A1 (Homo sapiens) 6480464 quercitrin affects the expression of CSNK2A1 mRNA CTD PMID:25193878 retinyl acetate increases expression ISO Csnk2a1 (Mus musculus) 6480464 retinol acetate results in increased expression of CSNK2A1 mRNA CTD PMID:16772331 rotenone increases expression ISO CSNK2A1 (Homo sapiens) 6480464 Rotenone results in increased expression of CSNK2A1 mRNA CTD PMID:32368861 Salinomycin decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 salinomycin results in decreased expression of CSNK2A1 mRNA CTD PMID:19682730 SB 431542 multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSNK2A1 mRNA CTD PMID:27188386 selenium atom decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 Selenium results in decreased expression of CSNK2A1 mRNA CTD PMID:19244175 sodium arsenite increases expression ISO CSNK2A1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of CSNK2A1 mRNA and sodium arsenite results in increased expression of CSNK2A1 protein CTD PMID:18572023 sodium arsenite increases expression ISO Csnk2a1 (Mus musculus) 6480464 sodium arsenite results in increased expression of CSNK2A1 protein CTD PMID:29044176 staurosporine multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 Staurosporine affects the reaction [Formaldehyde affects the phosphorylation of CSNK2A1 protein] CTD PMID:36534342 sulindac decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 Sulindac results in decreased expression of CSNK2A1 mRNA CTD PMID:11906190 sulindac increases expression EXP 6480464 Sulindac results in increased expression of CSNK2A1 mRNA CTD PMID:24136188 tamoxifen affects expression ISO Csnk2a1 (Mus musculus) 6480464 Tamoxifen affects the expression of CSNK2A1 mRNA CTD PMID:17555576 trichloroethene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of CSNK2A1 mRNA CTD PMID:17905399 undecane decreases expression EXP 6480464 undecane results in decreased expression of CSNK2A1 protein CTD PMID:17337753 valproic acid decreases methylation ISO CSNK2A1 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of CSNK2A1 gene CTD PMID:29154799 valproic acid multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSNK2A1 mRNA CTD PMID:27188386 valproic acid decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CSNK2A1 mRNA CTD PMID:23179753 and PMID:26272509 valproic acid affects expression ISO CSNK2A1 (Homo sapiens) 6480464 Valproic Acid affects the expression of CSNK2A1 mRNA CTD PMID:25979313 valproic acid increases expression ISO CSNK2A1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of CSNK2A1 mRNA CTD PMID:29154799 valproic acid decreases expression ISO Csnk2a1 (Mus musculus) 6480464 Valproic Acid results in decreased expression of CSNK2A1 mRNA CTD PMID:21427059 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CSNK2A1 mRNA CTD PMID:19015723 vitamin E decreases expression ISO CSNK2A1 (Homo sapiens) 6480464 Vitamin E results in decreased expression of CSNK2A1 mRNA CTD PMID:19244175 zinc atom multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 2-dimethylamino-4 more ... CTD PMID:22317921 zinc(0) multiple interactions ISO CSNK2A1 (Homo sapiens) 6480464 2-dimethylamino-4 more ... CTD PMID:22317921